Colorectal Cancer Clinical Trials in Philadelphia

Showing 81-100 of 259 trials

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in combination with cemiplimab in patients with advanced solid tumors.

Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more

Sensei Biotherapeutics, Inc.98 participantsStarted May 2023

Los Angeles, California, United States • Aurora, Colorado, United States • Louisville, Kentucky, United States +7 more locations

COMPLETED< 1 mile

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

NCT04136002

The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.

Colorectal Cancer

Guardant Health, Inc.44,467 participantsStarted Oct 2019

Anniston, Alabama, United States • Guntersville, Alabama, United States • Huntsville, Alabama, United States +268 more locations

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Colorectal Cancer Trials in Other Cities

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

ColoCare Study - Colorectal Cancer Cohort

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Stage II/III Colorectal Cancer Recurrence

Other Conditions in Philadelphia